Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of BIIB074 in neuropathic pain from lumbosacral radiculopathy
2015-004796-68Phase 2Completed
- Sponsor
- Biogen
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vixotrigine in Neuralgia and lumbosacral radiculopathy, sponsored by Biogen. Primary endpoint: Primary: Long-term safety and tolerability of BIIB074. Started Aug 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
Neuralgialumbosacral radiculopathy
Beyond the preview
Go deeper on 2015-004796-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004796-68.